Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

2.

Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.

Guirguis-Blake J.

Am Fam Physician. 2012 Jul 1;86(1):21-3. Review. No abstract available.

3.

Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today?

Sandercock PA.

J Neurol Neurosurg Psychiatry. 2003 Nov;74(11):1461-4. No abstract available.

4.

When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.

Ahmad T, Patel CB, Milano CA, Rogers JG.

Circulation. 2012 Jun 12;125(23):2948-55. doi: 10.1161/CIRCULATIONAHA.112.097337. No abstract available.

5.

A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?

Rastegarpanah M, Malekzadeh F, Thomas GN, Mohagheghi A, Cheng KK, Marshall T.

Arch Iran Med. 2008 May;11(3):306-13. doi: 08113/AIM.0012. No abstract available.

6.

[Unrecognized myocardial infarction].

Matsumoto T.

Nihon Rinsho. 2007 Sep 28;Suppl 5 Pt 2:249-52. Review. Japanese. No abstract available.

PMID:
17952999
7.

Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines.

Biviano AB, Rabbani LE, Paultre F, Hurley E, Sullivan J, Giglio J, Mosca L.

Am J Cardiol. 2003 May 15;91(10):1248-50. No abstract available.

PMID:
12745113
8.

Do the current medical and economic times dictate the need for the "polypill"?

Rifai L, Khan BV.

J Clin Hypertens (Greenwich). 2009 Dec;11(12):775-6. doi: 10.1111/j.1751-7176.2009.00188.x. No abstract available.

9.

Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.

Latini R, Santoro E, Masson S, Tavazzi L, Maggioni AP, Franzosi MG, Barlera S, Calvillo L, Salio M, Staszewsky L, Labarta V, Tognoni G; GISSI-3 Investigators.

Heart Dis. 2000 May-Jun;2(3):185-90.

PMID:
11728260
10.

Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

Feher G, Koltai K, Papp E, Alkonyi B, Solyom A, Kenyeres P, Kesmarky G, Czopf L, Toth K.

Drugs Aging. 2006;23(7):559-67.

PMID:
16930084
11.

Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction.

Dalal H, Evans PH, Campbell JL.

BMJ. 2004 Mar 20;328(7441):693-7. Review. No abstract available. Erratum in: BMJ. 2004 Apr 17;328(7445):926.

12.

Secondary prevention of ischaemic cardiac events.

Gami A.

Clin Evid. 2006 Jun;(15):195-228. Review. No abstract available.

PMID:
16973010
13.

Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.

Skinner JS, Minhas R.

Heart. 2007 Jul;93(7):864-6. No abstract available.

14.

Modern adjunctive pharmacotherapy of myocardial infarction.

Prasad A, Reeder G.

Expert Opin Pharmacother. 2000 Mar;1(3):405-18. Review.

PMID:
11249526
16.

Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.

Hippisley-Cox J, Coupland C.

BMJ. 2005 May 7;330(7499):1059-63. Erratum in: BMJ. 2006 Apr 15;332(7546):912.

17.

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.

Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.

Am J Med. 2004 Jul 15;117(2):73-81.

PMID:
15234641
18.

Pharmacological approach to patients with non-ST segment elevation myocardial infarction: does sex make a difference?

Janion-Sadowska A, Sielski J, Gierlotka M, Nowalany-Kozielska E, Janion M, PoloĊ„ski L.

Pol Arch Med Wewn. 2011 Jan-Feb;121(1-2):18-22.

19.

[Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].

Pedrinelli R, Ciccone M, Novo S, Catapano AL.

G Ital Cardiol (Rome). 2012 Nov;13(11):734-40. doi: 10.1714/1168.12949. Review. Italian.

PMID:
23096582
20.

Primary prevention of myocardial infarction: putting the evidence to use.

Herzog E, Javed F.

Arch Intern Med. 2010 Aug 9;170(15):1381-2. doi: 10.1001/archinternmed.2010.266. No abstract available.

PMID:
20696965
Items per page

Supplemental Content

Write to the Help Desk